Advice
Product overview
Product overview
The content of this evidence summary was up to date in December 2020. See summaries of product characteristics, British National Formulary (BNF) or the Medicines and Healthcare products Regulatory Agency (MHRA) or the NICE websites for up-to-date information.
Delafloxacin (Quofenix, Menarini) is a fluoroquinolone antibiotic, which is available as a powder for infusion and a tablet. It has a marketing authorisation for treating acute bacterial skin and skin structure infections (ABSSSI) in adults when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections.